GOCO - GoHealth, Inc.
NASDAQ
->
Financial Services
->
Insurance Brokers
Chicago,
United States
Type: Equity
GOCO price evolution
GOCO
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.39 | $25.36 | $32.33 | $16.46 |
| Short term investments | ||||
| Net receivables | $908.16 | $947.55 | $962.99 | $340.5 |
| Inventory | ||||
| Total current assets | $346.32 | $368.1 | $375.46 | $414.56 |
| Long term investments | ||||
| Property, plant & equipment | $48.28 | $41.09 | $45.25 | $46.77 |
| Goodwill & intangible assets | $430.07 | $453.58 | $477.1 | $500.61 |
| Total noncurrent assets | $1091.09 | $1114.15 | $1167.99 | $1244.73 |
| Total investments | ||||
| Total assets | $1437.41 | $1482.25 | $1543.45 | $1659.29 |
| Current liabilities | ||||
| Accounts payable | $330.9 | $333.31 | $340.84 | $15.15 |
| Deferred revenue | $42.82 | $27.72 | $25.68 | $50.59 |
| Short long term debt | $5.79 | $6.76 | $26.61 | $14.24 |
| Total current liabilities | $217.78 | $210.26 | $209.81 | $265.45 |
| Long term debt | $537.78 | $531.46 | $526.95 | $504.81 |
| Total noncurrent liabilities | $815.02 | $811.24 | $810.35 | $851.44 |
| Total debt | $543.57 | $538.22 | $553.56 | $557.42 |
| Total liabilities | $1032.8 | $1021.49 | $1020.15 | $1341.23 |
| Shareholders' equity | ||||
| Retained earnings | -$419.05 | -$395.14 | -$366.2 | -$357.02 |
| Other shareholder equity | -$0.06 | -$0.13 | -$0.14 | -$0.14 |
| Total shareholder equity | $227.93 | $249.91 | $263.51 | $268.76 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $16.46 | $84.36 | $144.23 | $12.28 |
| Short term investments | ||||
| Net receivables | $340.5 | $1279.78 | $840.66 | $125.54 |
| Inventory | ||||
| Total current assets | $414.56 | $429 | $391.82 | $143.77 |
| Long term investments | ||||
| Property, plant & equipment | $46.77 | $47.73 | $17.35 | $6.34 |
| Goodwill & intangible assets | $500.61 | $594.67 | $1075.28 | |
| Total noncurrent assets | $1244.73 | $1639.86 | $1716.97 | $1458.53 |
| Total investments | ||||
| Total assets | $1659.29 | $2068.85 | $2108.8 | $1602.3 |
| Current liabilities | ||||
| Accounts payable | $15.15 | $418.41 | $269.81 | $13.58 |
| Deferred revenue | $50.59 | $0.54 | $0.74 | $15.22 |
| Short long term debt | $14.24 | $11.4 | $4.17 | $3 |
| Total current liabilities | $265.45 | $217.07 | $127.37 | $113.06 |
| Long term debt | $504.81 | $684.89 | $396.4 | $288.23 |
| Total noncurrent liabilities | $851.44 | $959.29 | $582.27 | $629.09 |
| Total debt | $557.42 | $696.29 | $400.57 | |
| Total liabilities | $1341.23 | $1176.36 | $709.64 | $742.15 |
| Shareholders' equity | ||||
| Retained earnings | -$357.02 | -$208.32 | -$18.8 | |
| Other shareholder equity | -$0.14 | -$0.06 | $0.02 | -$0.02 |
| Total shareholder equity | $268.76 | $353.1 | $380.42 | $312.6 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $132.04 | $142.78 | $183.16 | $69.38 |
| Cost of revenue | $35.99 | $36.42 | $45.46 | $20.63 |
| Gross Profit | $96.05 | $106.36 | $137.7 | $48.75 |
| Operating activities | ||||
| Research & development | $11.65 | $10.51 | $9.54 | $11.53 |
| Selling, general & administrative | $52.38 | $77.12 | $68.36 | $81.82 |
| Total operating expenses | $134.02 | $159.37 | $143.44 | $181.93 |
| Operating income | -$37.98 | -$53.02 | -$5.75 | -$133.18 |
| Income from continuing operations | ||||
| EBIT | -$6.45 | -$11.75 | $7.67 | -$43.79 |
| Income tax expense | -$0.11 | -$0.07 | -$0.04 | $0.29 |
| Interest expense | $17.57 | $17.27 | $16.89 | $17.32 |
| Net income | ||||
| Net income | -$23.91 | -$28.94 | -$9.18 | -$61.4 |
| Income (for common shares) | -$23.91 | -$28.94 | -$9.18 | -$61.4 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $631.67 | $1062.41 | $877.35 | $539.5 |
| Cost of revenue | $187.67 | $239.34 | $199.2 | $169.55 |
| Gross Profit | $444 | $823.08 | $678.15 | $369.95 |
| Operating activities | ||||
| Research & development | $46.09 | $48.43 | $59.35 | $46.32 |
| Selling, general & administrative | $324.09 | $463.32 | $404.09 | $248.98 |
| Total operating expenses | $762.67 | $1312.53 | $722.99 | $493.07 |
| Operating income | -$318.67 | -$489.45 | -$44.85 | $46.44 |
| Income from continuing operations | ||||
| EBIT | -$90.87 | -$155.88 | -$11.26 | $46.44 |
| Income tax expense | $0.76 | -$0.02 | $0.04 | -$0.02 |
| Interest expense | $57.07 | $33.51 | $32.97 | -$8.22 |
| Net income | ||||
| Net income | -$148.71 | -$189.36 | -$44.27 | -$41.07 |
| Income (for common shares) | -$148.71 | -$189.36 | -$44.27 | $15.99 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$23.91 | -$28.94 | -$9.18 | -$61.4 |
| Operating activities | ||||
| Depreciation | $27.28 | $27.32 | $27.38 | $26.53 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.17 | $8.68 | $4.44 | $4.37 |
| Total cash flows from operations | $6.5 | $10.86 | $20.48 | -$41 |
| Investing activities | ||||
| Capital expenditures | -$3.43 | -$2.43 | -$2.23 | -$1.42 |
| Investments | ||||
| Total cash flows from investing | -$3.43 | -$2.43 | -$2.23 | -$1.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1.37 | -$0.53 | -$0.11 | -$0.34 |
| Net borrowings | $0.07 | -$14.01 | -$1.39 | -$156.25 |
| Total cash flows from financing | -$2.19 | -$15.43 | -$2.4 | -$156.59 |
| Effect of exchange rate | $0.14 | $0.04 | $0.01 | $0.07 |
| Change in cash and equivalents | $1.02 | -$6.96 | $15.86 | -$198.94 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Net income | -$148.71 | -$189.36 | -$44.27 | -$41.07 |
| Operating activities | ||||
| Depreciation | $111.02 | $112.54 | $98.55 | $8.64 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $27.14 | $27.3 | $216.23 | |
| Total cash flows from operations | $60.9 | -$299.01 | -$114.22 | -$0 |
| Investing activities | ||||
| Capital expenditures | -$13.51 | -$19.8 | -$14.52 | -$8.02 |
| Investments | ||||
| Total cash flows from investing | -$13.51 | -$19.8 | -$14.52 | -$815.61 |
| Financing activities | ||||
| Dividends paid | -$0.4 | |||
| Sale and purchase of stock | -$0.34 | $862.41 | ||
| Net borrowings | -$163.07 | $259.09 | $103.14 | $295.45 |
| Total cash flows from financing | -$115.05 | $259.09 | $260.66 | $827.43 |
| Effect of exchange rate | -$0.24 | -$0.15 | $0.04 | -$0.05 |
| Change in cash and equivalents | -$67.9 | -$59.87 | $131.96 | $11.77 |
News
Fundamentals
| Market cap | $295.69M |
|---|---|
| Enterprise value | $812.87M |
| Shares outstanding | 22.37M |
| Revenue | $527.35M |
|---|---|
| EBITDA | $54.19M |
| EBIT | -$54.33M |
| Net Income | -$123.43M |
| Revenue Q/Q | -0.76% |
| Revenue Y/Y | -47.89% |
| P/E ratio | -2.40 |
|---|---|
| EV/Sales | 1.54 |
| EV/EBITDA | 15.00 |
| EV/EBIT | -14.96 |
| P/S ratio | 0.56 |
| P/B ratio | 1.30 |
| Book/Share | 10.19 |
| Cash/Share | 1.18 |
| EPS | -$5.52 |
|---|---|
| ROA | -8.06% |
| ROE | -48.88% |
| Debt/Equity | 4.99 |
|---|---|
| Net debt/EBITDA | 18.57 |
| Current ratio | 1.59 |
| Quick ratio | 1.59 |